97 related articles for article (PubMed ID: 9412782)
41. Branching enzyme deficiency: expanding the clinical spectrum.
Paradas C; Akman HO; Ionete C; Lau H; Riskind PN; Jones DE; Smith TW; Hirano M; Dimauro S
JAMA Neurol; 2014 Jan; 71(1):41-7. PubMed ID: 24248152
[TBL] [Abstract][Full Text] [Related]
42. Long term longitudinal study of muscle function in patients with glycogen storage disease type IIIa.
Decostre V; Laforêt P; De Antonio M; Kachetel K; Canal A; Ollivier G; Nadaj-Pakleza A; Petit FM; Wahbi K; Fayssoil A; Eymard B; Behin A; Labrune P; Hogrel JY
Mol Genet Metab; 2017 Nov; 122(3):108-116. PubMed ID: 28888851
[TBL] [Abstract][Full Text] [Related]
43. Pathological modeling of glycogen storage disease type III with CRISPR/Cas9 edited human pluripotent stem cells.
Rossiaud L; Fragner P; Barbon E; Gardin A; Benabides M; Pellier E; Cosette J; El Kassar L; Giraud-Triboult K; Nissan X; Ronzitti G; Hoch L
Front Cell Dev Biol; 2023; 11():1163427. PubMed ID: 37250895
[No Abstract] [Full Text] [Related]
44. Clinical and Functional Characterization of Novel AGL Variants in Two Families with Glycogen Storage Disease Type III.
Yu T; Fu H; Yang A; Liang Y
Int J Endocrinol; 2023; 2023():6679871. PubMed ID: 37287601
[TBL] [Abstract][Full Text] [Related]
45. Polyglucosan bodies in intramuscular nerve branches are a poor predictor of GBE1 mutation and adult polyglucosan body disease.
Furtado LV; Kadri S; Wurst MN; Long BC; Segal JP; Pytel P
Muscle Nerve; 2016 Mar; 53(3):473-5. PubMed ID: 26670585
[TBL] [Abstract][Full Text] [Related]
46. Anesthetic management for dental surgery in a child with glycogen storage disease type IIIa: a case report.
Aykenar B; Çekmen N
J Dent Anesth Pain Med; 2022 Dec; 22(6):451-455. PubMed ID: 36601131
[TBL] [Abstract][Full Text] [Related]
47. Nutritional management of glycogen storage disease type III: a case report and a critical appraisal of the literature.
Massimino E; Amoroso AP; Lupoli R; Rossi A; Capaldo B
Front Nutr; 2023; 10():1178348. PubMed ID: 37252245
[TBL] [Abstract][Full Text] [Related]
48. Adult polyglucosan body disease-an atypical compound heterozygous with a novel GBE1 mutation.
Carvalho A; Nunes J; Taipa R; Melo Pires M; Pinto Basto J; Barros P
Neurol Sci; 2021 Jul; 42(7):2955-2959. PubMed ID: 33517539
[TBL] [Abstract][Full Text] [Related]
49. A 10-Month-Old Male With a Cough, Fever, and Abnormal Hepatitis Serologies.
Stonko DP; Crook TW
Clin Pediatr (Phila); 2017 Jun; 56(6):593-595. PubMed ID: 27400933
[No Abstract] [Full Text] [Related]
50. [The clinicopathological characteristics and genetic analysis of a case of late onset glycogen storage disease type Ⅱ caused by a novel deletion mutation].
Sun AP; Liu XY; Zhang YS
Zhonghua Nei Ke Za Zhi; 2017 Dec; 56(12):943-945. PubMed ID: 29202537
[No Abstract] [Full Text] [Related]
51. [A case of glycogen storage disease type II and related analysis].
Han JM; Zhang LY; Sun L; Lu Y; Li MH
Zhonghua Gan Zang Bing Za Zhi; 2017 Dec; 25(12):942-943. PubMed ID: 29325298
[No Abstract] [Full Text] [Related]
52. Two new mutations in the 3' coding region of the glycogen debranching enzyme in a glycogen storage disease type IIIa Ashkenazi Jewish patient.
Parvari R; Shen J; Hershkovitz E; Chen YT; Moses SW
J Inherit Metab Dis; 1998 Apr; 21(2):141-8. PubMed ID: 9584265
[TBL] [Abstract][Full Text] [Related]
53. Prenatal diagnosis and carrier detection for glycogen storage disease type III using polymorphic DNA markers.
Shen J; Liu HM; McConkie-Rosell A; Chen YT
Prenat Diagn; 1998 Jan; 18(1):61-4. PubMed ID: 9483641
[TBL] [Abstract][Full Text] [Related]
54. Glycogen storage disease type III: a mixed-methods study to assess the burden of disease.
Evins A; Mayhew J; Cimms T; Whyte J; Vong K; Hribal E; Evans CJ; Grimm A
Ther Adv Endocrinol Metab; 2024; 15():20420188231224233. PubMed ID: 38196773
[TBL] [Abstract][Full Text] [Related]
55. French recommendations for the management of glycogen storage disease type III.
Wicker C; Cano A; Decostre V; Froissart R; Maillot F; Perry A; Petit F; Voillot C; Wahbi K; Wenz J; Laforêt P; Labrune P
Eur J Med Res; 2023 Jul; 28(1):253. PubMed ID: 37488624
[TBL] [Abstract][Full Text] [Related]
56. Glycogen storage diseases: An update.
Gümüş E; Özen H
World J Gastroenterol; 2023 Jul; 29(25):3932-3963. PubMed ID: 37476587
[TBL] [Abstract][Full Text] [Related]
57. Evaluation of Glycogen Storage Patients: Report of Twelve Novel Variants and New Clinical Findings in a Turkish Population.
Ersoy M; Uyanik B; Gedikbasi A
Genes (Basel); 2021 Dec; 12(12):. PubMed ID: 34946936
[TBL] [Abstract][Full Text] [Related]
58. The Novel Compound Heterozygous Mutations in the AGL Gene in a Chinese Family With Adult Late-Onset Glycogen Storage Disease Type IIIa.
Qu Q; Qian Q; Shi J; Liu H; Zhang Y; Cui W; Chen P; Lv H
Front Neurol; 2020; 11():554012. PubMed ID: 33329302
[No Abstract] [Full Text] [Related]
59. Incidence of inherited metabolic disorders in southern Israel: a comparison between consanguinity and non-consanguinity communities.
Hazan G; Hershkovitz E; Staretz-Chacham O
Orphanet J Rare Dis; 2020 Nov; 15(1):331. PubMed ID: 33239050
[TBL] [Abstract][Full Text] [Related]
60.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
